WCMN
ABBV icon

Westchester Capital Management (Nebraska)’s AbbVie ABBV Stock Holding History

Westchester Capital Management (Nebraska)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Sell
102,641
-1,002
-1% -$216K 4.65% 9
2026
Q1 		$22.5M Buy
103,643
+1,372
+1% +$304K 4.54% 8
2025
Q4 		$23.4M Sell
102,271
-1,651
-2% -$376K 4.83% 8
2025
Q3 		$24.1M Sell
103,922
-868
-0.8% -$177K 5.17% 8
2025
Q2 		$19.5M Buy
104,790
+1,010
+1% +$188K 4.58% 9
2025
Q1 		$21.7M Sell
103,780
-368
-0.4% -$71.5K 5.41% 5
2024
Q4 		$18.5M Sell
104,148
-1,442
-1% -$265K 4.65% 8
2024
Q3 		$20.9M Sell
105,590
-1,105
-1% -$206K 5.06% 6
2024
Q2 		$18.3M Buy
106,695
+5,213
+5% +$864K 4.62% 9
2024
Q1 		$18.5M Sell
101,482
-1,785
-2% -$308K 4.64% 7
2023
Q4 		$16M Sell
103,267
-830
-0.8% -$121K 4.31% 7
2023
Q3 		$15.5M Buy
104,097
+276
+0.3% +$40.5K 4.44% 6
2023
Q2 		$14M Buy
103,821
+173
+0.2% +$25.4K 3.89% 10
2023
Q1 		$16.5M Sell
103,648
-2,681
-3% -$410K 4.75% 5
2022
Q4 		$17.2M Sell
106,329
-4,232
-4% -$649K 5.06% 5
2022
Q3 		$14.8M Sell
110,561
-194
-0.2% -$27.8K 4.79% 5
2022
Q2 		$17M Sell
110,755
-146
-0.1% -$22.3K 5.18% 4
2022
Q1 		$18M Sell
110,901
-1,215
-1% -$176K 4.64% 4
2021
Q4 		$15.2M Sell
112,116
-2,242
-2% -$265K 3.88% 11
2021
Q3 		$12.3M Sell
114,358
-385
-0.3% -$44K 3.44% 16
2021
Q2 		$12.9M Sell
114,743
-1,727
-1% -$195K 3.63% 12
2021
Q1 		$12.6M Sell
116,470
-532
-0.5% -$56.9K 3.65% 12
2020
Q4 		$12.5M Sell
117,002
-946
-0.8% -$90.9K 3.96% 8
2020
Q3 		$10.3M Sell
117,948
-139
-0.1% -$13.1K 3.67% 14
2020
Q2 		$11.6M Buy
118,087
+518
+0.4% +$45.6K 4.37% 5
2020
Q1 		$8.96M Sell
117,569
-1,397
-1% -$119K 4% 13
2019
Q4 		$10.5M Buy
118,966
+3,199
+3% +$266K 3.67% 16
2019
Q3 		$8.77M Buy
115,767
+2,353
+2% +$161K 3.44% 19
2019
Q2 		$8.25M Buy
113,414
+8,235
+8% +$647K 3.23% 20
2019
Q1 		$8.48M Sell
105,179
-1,640
-2% -$134K 3.63% 17
2018
Q4 		$9.85M Sell
106,819
-3,614
-3% -$318K 4.58% 6
2018
Q3 		$10.4M Sell
110,433
-290
-0.3% -$27.5K 4.14% 9
2018
Q2 		$10.3M Sell
110,723
-513
-0.5% -$50.1K 4.36% 8
2018
Q1 		$10.5M Sell
111,236
-7,009
-6% -$770K 4.44% 9
2017
Q4 		$11.4M Sell
118,245
-29,253
-20% -$2.76M 4.7% 6
2017
Q3 		$13.1M Buy
147,498
+155
+0.1% +$11.8K 5.62% 1
2017
Q2 		$10.7M Buy
147,343
+2,509
+2% +$169K 4.87% 3
2017
Q1 		$9.44M Sell
144,834
-2,085
-1% -$131K 4.53% 3
2016
Q4 		$9.2M Sell
146,919
-4,465
-3% -$273K 4.59% 5
2016
Q3 		$9.55M Sell
151,384
-8,040
-5% -$520K 4.64% 3
2016
Q2 		$9.87M Sell
159,424
-1,100
-0.7% -$67K 4.37% 5
2016
Q1 		$9.17M Buy
160,524
+5,796
+4% +$323K 4.13% 8
2015
Q4 		$9.17M Sell
154,728
-1,200
-0.8% -$69.1K 4.52% 4
2015
Q3 		$8.48M Sell
155,928
-1,525
-1% -$99.3K 4.54% 4
2015
Q2 		$10.6M Sell
157,453
-522
-0.3% -$34.1K 5.05% 1
2015
Q1 		$9.25M Buy
157,975
+275
+0.2% +$16.6K 4.57% 4
2014
Q4 		$10.3M Sell
157,700
-2,950
-2% -$186K 4.95% 1
2014
Q3 		$9.28M Buy
160,650
+275
+0.2% +$15.3K 4.39% 4
2014
Q2 		$9.05M Buy
+160,375
New +$8.41M 4.26% 3

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Westchester Capital Management (Nebraska)'s ABBV Position: Q2 2026 in Review

Westchester Capital Management (Nebraska) reduced its AbbVie (ABBV) stake by 0.97% in Q2 2026, selling an estimated $216K and leaving 102,641 shares worth $25.8M. The position accounts for 4.65% of the portfolio, ranked #9.

Westchester Capital Management (Nebraska) first reported a position in ABBV in Q2 2014 and has held it in 49 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Westchester Capital Management (Nebraska) held 102,641 shares of AbbVie worth $25.8M as of Q2 2026.
  • Westchester Capital Management (Nebraska) sold 1,002 AbbVie shares in Q2 2026, an estimated $216K.
  • AbbVie made up 4.65% of Westchester Capital Management (Nebraska)'s portfolio in Q2 2026, its #9 holding.
  • Westchester Capital Management (Nebraska) first reported a position in AbbVie in Q2 2014 and has held it in 49 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Westchester Capital Management (Nebraska)'s 13F filing for Q2 2026, filed 23 Jul 2026.